The mission of the AYA-O POWER program is to provide oncology trainees with high-yield education and resources to improve care delivery and outcomes for all adolescents and young adults (AYAs) diagnosed with cancer.
The goals of the program are:
To provide accessible, high-yield AYA-O education to increase oncology providers’ knowledge and comfort in caring for AYAs with cancer.
To enhance provider awareness of the gaps in care and outcomes for AYAs with cancer.
To improve AYA-O patient care by educating oncology providers on the unique needs of AYA cancer patients and survivors.
Get notified when new webcasts are available!
Managing the financial costs and associated challenges of cancer care and survivorship for AYAs is critical. This session will provide real life examples of financial toxicity to illustrate the importance of assessing and advocating for your patients from the start.
This session will focus on 7 core domains of high quality care and will discuss these areas and ways to support patient-centered care in each domain
This session will focus on data regarding substance use and abuse in oncology patients and survivors, the importance of addressing substance use in oncology, and how to address these topics with patients.
This presentation on Best Practices in Pediatric, Adolescent, and Young Adult Oncofertility seeks to present strategies to improve outcomes for this population with an equity lens.
This presentation will include how to communicate with AYAs about sexual health, nuts and bolts for how to identify and assess common problems, and practical strategies for helpful intervention.
This presentation will review key disparities in AYA survival and health-related quality of life, sociodemographic and clinical variables associated with poorer health and survival outcomes, and opportunities to mitigate these disparities.
The emergence of the field of adolescent and young adult (AYA) oncology was led by analyses of the epidemiology of cancer occurring across a span of ages from childhood to older adulthood. This presentation will review the epidemiology of AYA cancer and the unique biology associated with cancers diagnosed in the AYA age range.
Oregon Health and Science University
Oregon Health and Science University
Dr. Brandon Hayes-Lattin serves as Professor of Medicine and Deputy Division Head in the Division of Hematology and Medical Oncology at Oregon Health and Science University, and Director of the OHSU Knight Cancer Institute’s Adolescent and Young Adult (AYA) Oncology Program. His clinical background is in the management of hematologic malignancies and the use of cellular therapies and hematopoietic stem cell transplantation. e.
MD Anderson Cancer Center
MD Anderson Cancer Center
Dr. Roth is a Professor of Pediatrics at MD Anderson Cancer Center where he is co-Director of the Adolescent and Young Adult Program and Director of the Childhood Cancer Survivorship Program. Within the Children’s Oncology Group he is Chair of the AYA Oncology Discipline Committee and leads the AYA Responsible Investigator Network. He has a particular interest in improving the long-term health, survival, and quality of life for all AYAs diagnosed with cancer.
Dana Farber Cancer Institute
Dana Farber Cancer Institute
Dr. Bober is a Senior Psychologist at the Dana-Farber Cancer Institute and Associate Professor in the Dept. of Psychiatry at Harvard Medical School. She is the Founding Director of the Sexual Health Program at the Dana-Farber, a multi-disciplinary program that provides care for survivors of adult and pediatric cancer. Dr. Bober’s research efforts include a focus on developing sexual health interventions after cancer. In addition, Dr. Bober regularly teaches about how to address the topic of sexuality with patients and survivors.
The University of Colorado School of Medicine and Children's Hospital Colorado
The University of Colorado School of Medicine and Children's Hospital Colorado
Dr. Leslie Appiah is a Professor of Obstetrics and Gynecology and Chief of the Division of Academic Specialists in Obstetrics and Gynecology at The University of Colorado School of Medicine and Children’s Hospital Colorado. She is a fellowship-trained pediatric and adolescent gynecologist and Director of the Fertility Preservation and Reproductive Late Effects program at the Comprehensive Cancer Center and Center for Cancer and Blood Disorders. Dr. Appiah received her medical degree from the University of Texas Southwestern Medical School and completed residency at Sinai Medical Center in Baltimore, MD.
Dana Farber Cancer Institute and Boston Children's Hospital
Dana Farber Cancer Institute and Boston Children's Hospital
Dr. Mack received her medical degree from Harvard Medical School 1998. She subsequently completed her residency in Pediatrics and her fellowship in Pediatric Hematology Oncology at Boston Children's Hospital and the Dana-Farber Cancer Institute in Boston, MA. In 2005, Dr. Mack received a Master’s Degree in Public Health from the Harvard School of Public Health.
Emory University and Children's Healthcare of Atlanta
Emory University and Children's Healthcare of Atlanta
Dr. Effinger is an Associate Professor of Pediatrics at Emory University and the Medical Director of the Survivor Program in the Aflac Cancer and Blood Disorders Center at Children's Healthcare of Atlanta. She is a Section Leader for 3 Children's Oncology Group Long-term Follow-up Guidelines Committee Task Forces and is the Institutional PI for the Childhood Cancer Survivor Study. Her research focuses on improving the health and quality of life of survivors with a particular focus on healthy lifestyle behaviors in AYA survivors.
Tufts University School of Medicine and Tufts Medical Center
Tufts University School of Medicine and Tufts Medical Center
Dr. Parsons is a Professor of Medicine and Pediatrics at Tufts University School of Medicine and Medical Director of the Reid R. Sacco AYA Cancer Program at Tufts Medical Center. Her research has focused on strategies to improve the patient’s experience with healthcare, reduce regimen-related toxicity, and optimize functioning. Nationally, she serves as a member of the Children’s Oncology Group’s (COG) Steering Committees for AYA and Hodgkin Lymphoma (HL) and as a member of the study team of several frontline clinical trials in which patient-reported outcomes (PRO) have been embedded.
Wake Forest University School of Medicine
Wake Forest University School of Medicine
Dr. Salsman is a Professor in the Department of Social Sciences and Health Policy at the Wake Forest University School of Medicine where he serves as the Associate Director of Public Health Sciences for Charlotte and the Co-Leader of the Cancer Prevention and Control Program at the Atrium Health Wake Forest Baptist Comprehensive Cancer Center.
In 2021, the AYA Oncology Education Working Group was established to assess gaps in the AYA-O education provided to oncology trainees and develop educational interventions to address these knowledge gaps. The group included both pediatric and medical oncologists who practice at academic institutions and are active members of national oncology organizations. A needs assessment of pediatric and adult fellows and program directors was completed and found that 85% of programs lack a formal AYA curriculum, and nearly 50% of respondents reported little/no AYA topic specific education. AYA-O POWER aims to target this gap by providing live virtual lectures, as well as an online resource with additional educational materials and articles. We have partnered with the non-profit Elephants and Tea, who are helping organize and manage the program. Elephants and Tea’s commitment to improving AYA survivorship, their growth over their four years of existence within hospitals, and always wanting to tackle tough topics was the reason the AYA Oncology Education Working Group approached Elephants and Tea. Together, these two organizations look to break down barriers and ensure there is better education and resources for the oncology workforce for treating and understanding AYA’s facing cancer.
Elephants and Tea is a trademark of the Steven G. Cancer Foundation, a registered 501(c)(3) nonprofit under federal tax guidelines.